Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.69M | 50.90M | 39.51M | 48.80M | 71.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.63M | 1.27M | 1.52M | 1.82M | 1.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.32M | 2.39M | 1.94M | 2.56M | 2.60M |
| Total Current Assets | 34.65M | 54.56M | 42.97M | 53.17M | 75.81M |
|
|
|||||
| Total Current Assets | 34.65M | 54.56M | 42.97M | 53.17M | 75.81M |
| Net Property, Plant & Equipment | 604.00K | 2.34M | 2.89M | 3.47M | 2.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 530.00K | 567.00K | 609.00K | 949.00K | 1.24M |
| Total Assets | 35.78M | 57.47M | 46.47M | 57.60M | 79.90M |
|
|
|||||
| Total Accounts Payable | 6.22M | 9.17M | 8.03M | 3.00M | 4.03M |
| Total Accrued Expenses | 5.63M | 10.11M | 10.41M | 7.06M | 9.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.24M | 1.70M | 1.95M | 1.84M | 1.09M |
| Total Finance Division Other Current Liabilities | 120.00K | 63.00K | 105.00K | 443.00K | 419.00K |
| Total Other Current Liabilities | 120.00K | 63.00K | 105.00K | 443.00K | 419.00K |
| Total Current Liabilities | 13.20M | 21.04M | 20.50M | 12.33M | 15.24M |
|
|
|||||
| Total Current Liabilities | 13.20M | 21.04M | 20.50M | 12.33M | 15.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 201.00K | 755.00K | 724.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.43M | 24.86M | 2.26M | 2.26M | 2.26M |
| Total Liabilities | 31.63M | 45.90M | 22.97M | 15.35M | 18.23M |
|
|
|||||
| Common Stock & APIC | 320.82M | 319.14M | 312.33M | 304.35M | 302.54M |
| Retained Earnings | -316.67M | -307.57M | -288.83M | -262.11M | -240.87M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.15M | 11.57M | 23.50M | 42.24M | 61.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.15M | 11.57M | 23.50M | 42.24M | 61.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.15M | 11.57M | 23.50M | 42.24M | 61.67M |
|
|
|||||